Dandan Wang

Dandan Wang

Auto-generated profile, based on publicly available information

Dandan Wang

Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, and Howard Hughes Medical Institute, Boston, MA, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
XLXia Lv
Xia Lv
DWDan-Dan Wang
Dan-Dan Wang
LFLei Feng
Lei Feng
PWPing Wang
Ping Wang
LZLi-Wei Zou
Li-Wei Zou
LYLing Yang
Ling Yang
Human carboxylesterase 1 (hCE1), plays pivotal roles in endobiotics homeostasis and xenobiotic metabolism. The plasma level of hCE1 could serve as a useful serologic biomarker for several hepatic diseases, such as hepatocellular carcinoma. However, no probe reaction has been fruitfully used to determine the activity of trace hCE1 in human plasma. This study aims to design and develop a highly selective marker reaction for measuring the enzymatic activities of hCE1 in complex biological samples including human plasma. N-(4-Methyl butyrate)-4-hydroxy-1,8-naphthalimide (NMHN), which contains a small alcohol group and a large acyl moiety, was intentionally designed based on the substrate preference of hCE1. NMHN could be easily hydrolyzed by hCE1 with very high catalytic efficacy under physiological conditions, while both reaction-phenotyping assays and chemical inhibition assays demonstrated that this reaction exhibited super selectivity towards hCE1 over other human hydrolases. Furthermore, the marker reaction possessed ideal kinetic behaviour (classic Michaelis–Menten) with high intrinsic clearance (5.8 mL min−1 mg−1). Based on this probe, a rapid hCE1 quantification method was developed and fully validated, which was successfully applied to determine the real activities of hCE1 in various biological samples including human plasma. Our findings afforded a promising tool for measuring the real activity of hCE1 and laid a solid foundation for further investigations on the biological functions of hCE1 in complex biological samples.

25 August 2020 in Analytical Chemistry
Verified
Journal Article
Closed access
JZJie Zhang
Jie Zhang
XWXingyu Wang
Xingyu Wang
YWYi-Hui Wang
Yi-Hui Wang
DWDan-Dan Wang
Dan-Dan Wang
ZSZhen Song
Zhen Song
HWHuai-Song Wang
Huai-Song Wang

7 September 2016 in Applied Physics A
Verified
Journal Article
Closed access
PDF file
JLJihui Lang
Jihui Lang
YFYue Fang
Yue Fang
QZQi Zhang
Qi Zhang
JWJiaying Wang
Jiaying Wang
TLTianshun Li
Tianshun Li
JYJinghai Yang
Jinghai Yang

12 February 2026 in Science
Verified
Journal Article
Closed access
CAChristopher Auger
Christopher Auger
HNHiroshi Nishida
Hiroshi Nishida
BYBo Yuan
Bo Yuan
GSGuilherme Martins Silva
Guilherme Martins Silva
MFMasanori Fujimoto
Masanori Fujimoto
SKShingo Kajimura
Shingo Kajimura
Environmental adaptation often involves a shift in energy utilization toward mitochondrial fatty acid oxidation, which requires carnitine. Besides dietary sources of animal origin, carnitine biosynthesis from trimethyllysine (TML) is essential, particularly for those who consume plant-based diets; however, its molecular regulation and physiological role remain elusive. Here, we identify SLC25A45 as a mitochondrial TML carrier that controls carnitine biosynthesis and fuel switching. SLC25A45 deficiency decreased the carnitine pool and impaired mitochondrial fatty acid oxidation, shifting reliance to carbohydrate metabolism. Slc25a45 -deficient mice were cold-intolerant and resistant to lipid mobilization by glucagon-like peptide-1 receptor agonist (GLP-1RA), rendering them resistant to adipose tissue loss. Our study suggests that mitochondria serve as a regulatory checkpoint in fuel switching, with implications for metabolic adaptation and the efficacy of GLP-1RA–based anti-obesity therapy.

16 December 2025 in bioRxiv
Verified
Preprint
Open access
TYTadashi Yamamuro
Tadashi Yamamuro
DKDaisuke Katoh
Daisuke Katoh
GSGuilherme Martins Silva
Guilherme Martins Silva
HNHiroshi Nishida
Hiroshi Nishida
SOSatoshi Oikawa
Satoshi Oikawa
SKShingo Kajimura
Shingo Kajimura
SUMMARY: Mitochondria provide a variety of metabolites, in addition to ATP, to meet cell-specific needs. One such metabolite is phosphoenolpyruvate (PEP), which contains a higher-energy phosphate bond than ATP and has diverse biological functions. However, how mitochondria-generated PEP is delivered to the cytosol and fulfills cell-specific requirements remains elusive. Here, we show that SLC25A35 regulates mitochondrial PEP efflux and glyceroneogenesis in lipogenic cells that utilize the pyruvate-to-PEP bypass. Reconstitution and structural studies demonstrated PEP transport by SLC25A35 in a pH gradient-dependent manner. Loss of SLC25A35 in adipocytes impaired the conversion of mitochondrial PEP into glycerol-3-phosphate, thereby reducing glycerolipid synthesis. Significantly, hepatic inhibition of SLC25A35 in obese mice alleviated steatosis and improved systemic glucose homeostasis. Together, these results suggest that mitochondria facilitate glycerolipid synthesis by providing PEP via SLC25A35, offering lipogenic mitochondria as a target to limit glycerolipid synthesis, a pivotal step in the pathogenesis of hepatic steatosis and Type 2 diabetes.

31 July 2026 in Science Advances
Verified
Journal Article
Open access
SOSatoshi Oikawa
Satoshi Oikawa
TYTadashi Yamamuro
Tadashi Yamamuro
HNHiroshi Nishida
Hiroshi Nishida
DKDaisuke Katoh
Daisuke Katoh
DWDandan Wang
Dandan Wang
SKShingo Kajimura
Shingo Kajimura
Metabolic adaptation to nutrient deprivation requires coordinated control of mitochondrial anaplerosis and cataplerosis; however, how metabolite flux across the mitochondrial membrane is regulated during fasting remains less defined. Here, we report SLC25A34 as a fasting-inducible mitochondrial carrier that is highly expressed in oxidative skeletal muscle. Using bacterial reconstitution, proteo-liposomes, and tracer studies, we showed that SLC25A34 mediates the import of phosphoenolpyruvate (PEP) into the mitochondrial matrix. Loss of SLC25A34 impaired glutamine-supported anaplerosis under nutrient-deprived conditions, while glucose and pyruvate utilization remained largely intact. Muscle-specific deletion of Slc25a34 resulted in reduced fasting-induced amino acid catabolism and the accumulation of amino acids, leading to activation of mTORC1 signaling even under fasted conditions. Consequently, SLC25A34-deficient soleus muscle exhibited hypertrophy and myopathic features, accompanied by mTORC1-dependent increase in protein synthesis. Together, these results highlight a unique biological role for the inducible mitochondrial carrier SLC25A34, which couples PEP import to amino acid catabolism and proteostasis to preserve skeletal muscle integrity in response to metabolic stress.